Cell Therapeutics (CTIC) Files $150M Mixed Shelf
Cell Therapeutics, Inc. (Nasdaq: CTIC) filed a registration with the U.S. Securities and Exchange Commission to sell, from time to time, up to $150 million of Common Stock, Preferred Stock, Debt Securities, Warrants, Rights, Units, or any combination thereof.
You May Also Be Interested In
- Cell Therapeutics (CTIC) Higher after $5M Milestone Payment
- Clovis Oncology (CLVS) Prices 2M Share Offering at $57.50/sh
- Cathay General Bancorp (CATY) Files Mixed Shelf
Create E-mail Alert Related CategoriesEquity Offerings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!